All

Enterome Receives FDA IND Clearance for EO2463, an ‘OncoMimic’ based Immunotherapy Targeting Liquid Tumors
24 March 2021

Enterome Receives FDA IND Clearance for EO2463, an ‘OncoMimic’ based Immunotherapy Targeting Liquid Tumors

Phase1/2 clinical trials in patients with follicular lymphoma and marginal zone lymphoma expected to begin in Q2 2021

ENTEROME SA, a clinical stage biopharmaceutical...

Read the press release
Isabelle de Cremoux, CEO and Managing Partner, Seventure Partners explains Why investors need to think beyond ESG
18 March 2021

Isabelle de Cremoux, CEO and Managing Partner, Seventure Partners explains Why investors need to think beyond ESG

Calls for genuine corporate responsibility efforts have been high on the agenda for some time, but the pandemic — and its wide-ranging impact on all organisations, including...

Read more
Viva Wallet, PrestaShop partner to allow localised payments for online merchants
17 March 2021

Viva Wallet, PrestaShop partner to allow localised payments for online merchants

Viva Wallet and PrestaShop have partnered to allow online merchants across Europe and the UK to accept fully localised payments in a few clicks, via the Viva Wallet...

Read more
MaaT Pharma Announces Positive Topline Results from Phase 2 HERACLES Clinical Trial with Lead Microbiome Ecosystem Therapy MaaT013 in Patients with Acute Graft-versus-Host Disease
17 March 2021

MaaT Pharma Announces Positive Topline Results from Phase 2 HERACLES Clinical Trial with Lead Microbiome Ecosystem Therapy MaaT013 in Patients with Acute Graft-versus-Host Disease

MaaT Pharma announced today positive topline results from its Phase 2 clinical trial evaluating lead microbiome ecosystem therapy, MaaT013, in a high-risk patient population...

Read the press release
Hepster a german insurtech platform raises $10M Series A led by Element Ventures
5 March 2021

Hepster a german insurtech platform raises $10M Series A led by Element Ventures

Hepster, an insurtech platform from Germany, has raised $10 million in a Series A funding round led by Element Ventures. Also participating was Seventure Partners, MBMV and GPS...

Read more
YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders,  as well as the Inclusion of the Obese Patients in the Second Arm of the Trial
4 March 2021

YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders, as well as the Inclusion of the Obese Patients in the Second Arm of the Trial

YSOPIA Bioscience, a French clinical stage biotechnology company specializing in the research and development of innovative drugs using the properties of key bacterial strains...

Read the press release
IDnow Acquires identity Trust Management AG, a Leading Identity Verification Provider in Germany
3 March 2021

IDnow Acquires identity Trust Management AG, a Leading Identity Verification Provider in Germany

IDnow, a leading provider of Identity Verification-as-a-Service solutions, today announced that it has agreed to acquire identity Trust Management AG, a leading international...

Read more
BiomX Announces Dosing of First Subject in Phase 2 Study of BX001 for Acne-Prone Skin
2 March 2021

BiomX Announces Dosing of First Subject in Phase 2 Study of BX001 for Acne-Prone Skin

BiomX Inc. (NYSE American: PHGE), a clinical-stage company developing both natural and engineered phage therapies that target specific pathogenic bacteria, today announced that...

Read the press release
Izicap awarded “Best Pos/payment solution 2021” MPE AWARDS
25 February 2021

Izicap awarded “Best Pos/payment solution 2021” MPE AWARDS

Izicap, the european card-linked CRM & loyalty platform leader, has been awarded "Best POS/Payment Solution" by the merchant payments ecosystem organisation within their...

Read more
Launchmetrics and DBA Partner to Drive MIV for Influencers
11 February 2021

Launchmetrics and DBA Partner to Drive MIV for Influencers

Launchmetrics and Digital Brand Architects' campaign aims to drive Media Impact Value to influencers.

Read more

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse